CREATES Act of 2019
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Creating and Restoring Equal Access to Equivalent Samples Act of 2019 or the CREATES Act of 2019
This bill generally allows the developer of a drug or biological product, such as a generic or biosimilar version of a drug, to bring a civil action against the license holder of an approved medication if the holder refuses to make available sufficient quantities of the approved medication for the developer's testing. The bill also establishes affirmative defenses to such a civil action.
In addition, the bill authorizes drug manufacturers seeking Food and Drug Administration approval for a generic drug to use alternative methods to develop elements assure safe use of a drug.Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III.
- Introduced in House Formatted Text PDF Formatted XML
- Reported in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 965: CREATES Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-HR-965/
"H.R. 965: CREATES Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-965/.
H.R. 965, 116th Cong. (2026), https://openamerica.io/bill/116-HR-965/.
[H.R. 965: CREATES Act of 2019](https://openamerica.io/bill/116-HR-965/)